RecruitingNCT05619068
The Evolution and Prognosis of Moyamoya Disease
Studying Moyamoya disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chinese PLA General Hospital
- Principal Investigator
- Lou Xin, MD, PhDChinese PLA General Hospital
- Enrollment
- 300 target
- Eligibility
- 10-60 years · All sexes
- Timeline
- 2022 – 2027
Study locations (1)
- Chinese PLA General Hospital, Beijing, Beijing Municipality, China
Collaborators
Beijing Tiantan Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05619068 on ClinicalTrials.govOther trials for Moyamoya disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07304947Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya SurgerySeoul National University Hospital
- RECRUITINGNANCT07140731The Symani Restore StudyJacobs institute
- RECRUITINGNANCT07144930Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor ImpairmentsNational Taiwan University Hospital
- RECRUITINGPHASE1NCT07065409Treatment of Moyamoya Disease With iPSC-derived ExosomesHuaqiu Zhang
- RECRUITINGNCT06880341Managing Transient Neurologic Episodes in Surgery for Moyamoya DiseaseStanford University
- RECRUITINGNCT06832839Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya DiseaseBeijing Tiantan Hospital
- RECRUITINGNCT06817434Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya DiseaseBeijing Tiantan Hospital
- ENROLLING BY INVITATIONNANCT06477107A Study of Cerebral Perfusion With tDCS in Chronic HypoperfusionMayo Clinic